Triple-negative breast cancer: Immunohistochemical correlation with basaloid markers and prognostic value of survivin

Medical Oncology

Volumn 27, Issue 1, 2010, Pages 34-39

  Dogu, Gamze Gokoz ^a   Ozkan, Metin ^b   Ozturk, Figen ^b   Dikilitas, Mustafa ^b   Er, Ozlem ^b   Ozturk, Ahmet ^b  

^a Kayseri E itim Ve Ara tIrma Hospital   (Turkey)

^b ERCIYES UNIVERSITY   (Turkey)

Author keywords

Basaloid breast cancer; Prognosis; Survivin

Indexed keywords

CYTOKERATIN 14; CYTOKERATIN 17; CYTOKERATIN 5; CYTOKERATIN 6; EPIDERMAL GROWTH FACTOR RECEPTOR; SURVIVIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; STAINING; STATISTICAL SIGNIFICANCE; SURVIVAL;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-14; KERATIN-17; KERATIN-5; KERATIN-6; KERATINS; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR MARKERS, BIOLOGICAL;

EID: 77949266098     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-009-9166-3     Document Type: Article

References (18)

1. A Jemal R Siegel E Ward, et al. 2006 Cancer statistics, 2006 CA Cancer J Clin 56 106 130 10.3322/canjclin.56.2.106 16514137
2. CM Perou T Sorlie MB Eisen M van de Rijn SS Jeffrey CA Rees JR Pollack DT Ross H Johnsen LA Akslen 2000 Molecular portraits of human breast tumours Nature 406 747 752 10.1038/35021093 10.1038/35021093 1:CAS:528: DC%2BD3cXmt1CnsLw%3D 10963602 (Pubitemid 30671230)
3. T Sorlie CM Perou R Tibshirani T Aas S Geisler H Johnsen T Hastie MB Eisen M van de Rijn SS Jeffrey 2001 Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci USA 98 10869 10874 10.1073/pnas.191367098 10.1073/pnas.191367098 1:CAS:528:DC%2BD3MXntVGmsbo%3D 11553815 (Pubitemid 32878711)
4. T Sorlie R Tibshirani J Parker T Hastie JS Marron A Nobel, et al. 2003 Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci USA 100 8418 8423 10.1073/pnas.0932692100 1:CAS:528:DC%2BD3sXlsFGntLk%3D 12829800 (Pubitemid 36842560)
5. C Sotiriou SY Neo LM McShane EL Korn PM Long A Jazaeri P Martiat SB Fox AL Harris ET Liu 2003 Breast cancer classification and prognosis based on gene expression profiles from a population-based study Proc Natl Acad Sci USA 100 10393 10398 10.1073/pnas.1732912100 10.1073/pnas.1732912100 1:CAS:528: DC%2BD3sXntFynsrk%3D 12917485 (Pubitemid 37071889)
6. TO Nielsen FD Hsu K Jensen, et al. 2004 Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma Clin Cancer Res 10 5367 5374 10.1158/1078-0432.CCR-04-0220 10.1158/1078-0432.CCR-04- 0220 1:CAS:528:DC%2BD2cXmvFSlt7k%3D 15328174 (Pubitemid 39100473)
7. LA Carey CM Perou CA Livasy, et al. 2006 Race, breast cancer subtypes, and survival in the Carolin Breast Cancer Study JAMA 295 2492 2502 10.1001/jama.295.21.2492 10.1001/jama.295.21.2492 1:CAS:528:DC%2BD28XlsV2rtLw%3D 16757721 (Pubitemid 43854964)
8. M Van de Rijn CM Perou R Tibshirani, et al. 2002 Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome Am J Pathol 161 1991 1996 12466114
9. M Laakso N Loman A Borg, et al. 2005 Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors Mod Pathol 18 1321 1328 10.1038/modpathol.3800456 10.1038/modpathol.3800456 1:CAS:528:DC%2BD2MXhtVWiu7fI 15990899 (Pubitemid 41348650)
10. CS Duckett VE Nava RW Gedrich, et al. 1996 A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors EMBO J 14 2685 2694
11. SQ Zhang SY Qiang WB Yang JT Jiang ZZ Ji 2004 Expression of survivin in different stages of carcinogenesis and progression of breast cancer Ai Zheng 23 697 700 1:CAS:528:DC%2BD2cXhtVymu7nK 15191674
12. DC Altieri PC Marchisio 1999 Survivin apoptosis: an interloper between cell death and cell proliferation in cancer Lab Invest 79 1327 1333 1:STN:280:DC%2BD3c%2FktFKhsA%3D%3D 10576203
13. SM Kennedy L O'Driscoll R Purcell, et al. 2003 Prognostic importance of survivin in breast cancer Br J Cancer 88 1077 1083 10.1038/sj.bjc.6600776 10.1038/sj.bjc.6600776 1:CAS:528:DC%2BD3sXisFahsLs%3D 12671708 (Pubitemid 36560779)
14. EA Rakha JS Reis-Filho IO Ellis 2008 Basal-like breast cancer: a critical review J Clin Oncol 26 2568 2581 10.1200/JCO.2007.13.1748 10.1200/JCO.2007.13. 1748 18487574
15. S Gruvberger M Ringner Y Chen, et al. 2001 Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns Cancer Res 61 5979 5984 1:CAS:528:DC%2BD3MXmt12ktrw%3D 11507038
16. M Singh MJ Bleile AL Shroyer D Heinz EA Jarboe KR Shroyer 2004 Analysis of survivin expression in a spectrum of benign to malignant lesions of the breast Appl Immunohistochem Mol Morphol 12 4 296 304 10.1097/00129039-200412000- 00003 1:CAS:528:DC%2BD2cXhtFagsrjJ 15536328
17. DC Altieri 2001 The molecular basis and potential role of survivin in cancer diagnosis and therapy Trends Mol Med 7 542 547 10.1016/S1471-4914(01) 02243l-2 10.1016/S1471-4914(01)02243-2 1:CAS:528:DC%2BD3MXovVCnu70%3D 11733216
18. K Tanaka S Iwamoto G Gon, et al. 2000 Expression of survivin and its relationship to loss of apoptosis in breast carcinomas Clin Cancer Res 6 127 134 1:CAS:528:DC%2BD3cXhtVCjsr4%3D 10656440